Logo

Shares in Sequenom Jump 9 Percent On News of DNA Methylation Service Business Launch

Oct 27, 2005

NEW YORK, Oct. 27 (GenomeWeb News) - Sequenom introduced a DNA methylation and quantitative gene expression analysis service business yesterday.

 

Shares in the company were trading up 9 percent, or $.06, at $.72 in mid-afternoon trading.

 

Through the service, researchers can access Sequenom's MassArray solution for quantitative analysis and profiling of DNA methylation and gene expression. The company applies its iPLEX multiplexing assay to quantitative methylation profiling and quantitative gene expression analysis.

 

Sequenom said it intends to make DNA methylation and QGE analysis available as application products for the MassARRAY platform in the first quarter of 2006.

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.